Pharmaceutical Technology

JUNE 12, 2025

The drugmaker’s flagship drug semaglutide, known under the brand names Wegovy and Ozempic for obesity and type 2 diabetes treatment respectively, targets the glucagon-like peptide-1 receptor (GLP-1R), a key component of the incretin system. Can pharma tariffs “Make America Manufacture Again”?

Diabetes 59

Diabetes Compounding Communication Hospitals 59

Pharmaceutical Technology

JUNE 6, 2025

Find out more RTU cartridges are essential for storing glucagon-like peptide-1 drugs, biologics, insulin and hormone therapies used for treating diabetes, obesity and other immunological conditions. Can pharma tariffs “Make America Manufacture Again”? It will further extend the site’s manufacturing capabilities for high-value solutions.

Health and Personal Care Stores 52

Health and Personal Care Stores Communication Diabetes Hospitals 52

Pharmaceutical Technology

JUNE 23, 2025

Eylea is approved in four indications in Europe: the treatment of ‘wet’ age-related macular degeneration (AMD), visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO), visual impairment due to diabetic macular oedema (DME) and visual impairment due to myopic choroidal neovascularisation (myopic CNV).

Biosimilars 52

Biosimilars Pharmaceutical Manufacturing Communication Hospitals 52

Pharmaceutical Technology

JUNE 18, 2025

The full UK test will also look at a person’s susceptibility to developing type 2 diabetes, prostate cancer and breast cancer. Can pharma tariffs “Make America Manufacture Again”? The test was also evaluated in a clinical trial conducted with the NHS to evaluate its ability to detect signs of cardiovascular disease.

Communication 52

Communication Hospitals Packaging Diabetes 52

Pharmaceutical Technology

JUNE 18, 2025

Find out more Fleischer said that the programme will provide more services for patients receiving its glucagon-like peptide 1 receptor agonist (GLP-1RA) semaglutide, which is marketed as Wegovy for weight loss and Ozempic in type 2 diabetes, including fitness and dietary advice. Can pharma tariffs “Make America Manufacture Again”?

Communication 52

Communication Hospitals Packaging Compounding 52

pharmaphorum

JUNE 27, 2025

Skip to main content Friday 27 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Drug Development 52

Drug Development Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Marketing Network

OCTOBER 27, 2020

Don ( PMN): That is really really cool and I think a relief to millions of diabetes sufferers probably around the world as one of the most extensive diseases. Robin (Guest): Just like any of the other like wearable track right it’s. Don ( PMN): Sure. Robin (Guest): And have Bluetooth-enabled and all of that. Robin (Guest): Absolutely.

Hospitals 52

Hospitals Packaging Communication Diabetes 52